What is Immunome, Inc.'s Market Cap?

Immunome, Inc.'s Market Cap is $3.0B, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s Enterprise Value?

Immunome, Inc.'s Enterprise Value is $2.8B, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s EV / EBITDA?

Immunome, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s Revenue (TTM)?

Immunome, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s Net Income (TTM)?

Immunome, Inc.'s Net Income (TTM) is -$254.3M, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s EBITDA?

Immunome, Inc.'s EBITDA is -$267.7M, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s Diluted EPS (TTM)?

Immunome, Inc.'s Diluted EPS (TTM) is -2.24, based on as-reported figures from SEC (XBRL) filings.

What is Immunome, Inc.'s Net Debt?

Immunome, Inc.'s Net Debt is -$217.7M, based on as-reported figures from SEC (XBRL) filings.

Immunome, Inc. (IMNM) Financial Statements

Immunome, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00BR94298

XNAS · usd

26.81▲ 0.05 (0.19%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close26.76

Day's Range25.91 – 27.25

52-Week Range8.67 – 30.06

Volume827.7K

Avg Volume1.0M

Share Statistics

Shares Outstanding

Employees177

ExchangeXNAS

Listed2020-10-02

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Immunome, Inc. (IMNM)

What is Immunome, Inc.'s Market Cap?: Immunome, Inc.'s Market Cap is $3.0B, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s Enterprise Value?: Immunome, Inc.'s Enterprise Value is $2.8B, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s EV / EBITDA?: Immunome, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s Revenue (TTM)?: Immunome, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s Net Income (TTM)?: Immunome, Inc.'s Net Income (TTM) is -$254.3M, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s EBITDA?: Immunome, Inc.'s EBITDA is -$267.7M, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s Diluted EPS (TTM)?: Immunome, Inc.'s Diluted EPS (TTM) is -2.24, based on as-reported figures from SEC (XBRL) filings.
What is Immunome, Inc.'s Net Debt?: Immunome, Inc.'s Net Debt is -$217.7M, based on as-reported figures from SEC (XBRL) filings.